|Post Brand Cereal|
Ralcorp instead has touted its plan to spin off its Post Cereals unit as one that offered superior value to shareholders. After ConAgra was rejected by Ralcorp three times, some analysts speculated ConAgra might go ahead and turn its bid hostile. ConAgra had said it was considering its options after the latest rejection. Late Tuesday, ConAgra said Ralcorp's board was "singularly focused" on its Post spinoff, refusing any attempts at M&A negotiations. ConAgra argued the "superior value and certainty" of its acquisition offer. ConAgra maintained that its offer represented a 44% premium to Ralcorp's March 21 closing price, the day before it made its initial bid; the maker of Chef Boyardee, Healthy Choice and Hebrew National food brands also said its bid was 32% higher than Ralcorp's all-time closing high. On Tuesday, Ralcorp shares closed up at $85.14, giving the $94 bid a 10% premium. Ralcorp shares were 10.3% lower in premarket trading on Wednesday, while ConAgra was up by 0.5% ahead of the opening bell.
For ConAgra, acquiring Ralcorp and its roster of private-label brands would help it bulk up its generic food brands and better compete with other private-label providers as consumers continue to trade down to lower-priced offerings. Still, if Ralcorp is unwilling to negotiate at all, ConAgra is left with few choices. Ralcorp is incorporated in Missouri, a state with strict anti-takeover laws that protect unwilling targets. Ralcorp also instituted a poison pill that protects against hostile buyers by making unwanted acquisitions very expensive to the buyer. Additionally, Ralcorp announced in early August its plan to buy Sara Lee's ( SLE) refrigerated dough business for $545 million as part of its own efforts to bulk up its private-label operations. -- Written by Miriam Marcus Reimer in New York.
>To contact the writer of this article, click here: Miriam Reimer.
>To follow the writer on Twitter, go to http://twitter.com/miriamsmarket.
>To submit a news tip, send an email to: email@example.com.
>>See our new stock quote page.